Author

Matthew Murray

Observed name: Murray, Matthew

Institution: University of Cambridge

Observed institution: University of Cambridge

ORCID: 0000-0002-4480-1147

Observed ORCID: 0000-0002-4480-1147

OpenAlex ID: A5122020239

8 MonoGerm: Phase II trial of carboplatin or vinblastine monotherapy prior to radiotherapy for intracranial germinoma, using novel proof-of-principle Bayesian design

2026 · Laura Kirton, John Apps, et al. · Neuro-Oncology

MonoGerm: A trial to test if using one chemotherapy drug is as good as using three chemotherapy drugs before radiotherapy for patients with germinoma brain tumours

2026 · . Study Team, Matthew Murray · http://isrctn.com/

Works count: 4

Citation count:

H-index:

I10-index: